# CGI Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cgi-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Branford, US
- Total disclosed funding: $61M
- Latest round: Series C (Jul 14, 2004)
- Investors on record: 11

## About

CGI Pharmaceuticals is based in US and operates as a drug discovery firm.

## Funding rounds

- Series C, Jul 14, 2004, $13M — Toucan Capital, RiverVest Ventures Partners, CDPQ, Coastview Capital, Connecticut Innovations
- Series C, Jan 21, 2004, $22M — Flagship Pioneering, Lilly Ventures, Coastview Capital, Connecticut Innovations, Emerging Technology Partners, Vector Fund Management, MPM BioImpact
- Series B, Mar 1, 2001, $22M — CHL Medical Partners, Connecticut Innovations, Vector Fund Management, MPM BioImpact
- Series A, Apr 1, 2000, $4.5M — CHL Medical Partners, Connecticut Innovations

## Investors

- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series A, Series B
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A, Series B, Series C
- Vector Fund Management (https://capitalatlas.ai/funds/vector-fund-management) — Series B, Series C
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series B, Series C
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series C
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series C
- Coastview Capital (https://capitalatlas.ai/funds/coastview-capital) — Series C
- Emerging Technology Partners (https://capitalatlas.ai/funds/emerging-technology-partners) — Series C
- Toucan Capital (https://capitalatlas.ai/funds/toucan-capital) — Series C
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series C
- CDPQ — Series C